|
Oncogenes and Tumor Suppressors
Citations 141-150 of 795 total displayed.
|
Past content
(since May 2000):
|
Hypusination of eukaryotic initiation factor 5A (eIF5A): a novel therapeutic target in BCR-ABL–positive leukemias identified by a proteomics approach
- Stefan Balabanov, Artur Gontarewicz, Patrick Ziegler, Ulrike Hartmann, Winfried Kammer, Mhairi Copland, Ute Brassat, Martin Priemer, Ilona Hauber, Thomas Wilhelm, Gerold Schwarz, Lothar Kanz, Carsten Bokemeyer, Joachim Hauber, Tessa L. Holyoake, Alfred Nordheim, and Tim H. Brümmendorf
Blood 2007; 109: 1701-1711.
[Abstract]
[Full text]
[PDF]
The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemia
- Vivian G. Oehler, Ted Gooley, David S. Snyder, Laura Johnston, Allen Lin, Carrie C. Cummings, Su Chu, Ravi Bhatia, Stephen J. Forman, Robert S. Negrin, Frederick R. Appelbaum, and Jerald P. Radich
Blood 2007; 109: 1782-1789.
[Abstract]
[Full text]
[PDF]
PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase
- Rebecca J. Chan and Gen-Sheng Feng
Blood 2007; 109: 862-867.
[Abstract]
[Full text]
[PDF]
Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features
- Brunangelo Falini, Ildo Nicoletti, Massimo F. Martelli, and Cristina Mecucci
Blood 2007; 109: 874-885.
[Abstract]
[Full text]
[PDF]
Commonly dysregulated genes in murine APL cells
- Wenlin Yuan, Jacqueline E. Payton, Matthew S. Holt, Daniel C. Link, Mark A. Watson, John F. DiPersio, and Timothy J. Ley
Blood 2007; 109: 961-970.
[Abstract]
[Full text]
[PDF]
Human T-cell leukemia virus type-1 Tax oncoprotein regulates G-protein signaling
- Jean-Claude Twizere, Jean-Yves Springael, Mathieu Boxus, Arsène Burny, Franck Dequiedt, Jean-François Dewulf, Julie Duchateau, Daniel Portetelle, Patrice Urbain, Carine Van Lint, Patrick L. Green, Renaud Mahieux, Marc Parmentier, Luc Willems, and Richard Kettmann
Blood 2007; 109: 1051-1060.
[Abstract]
[Full text]
[PDF]
Bcr-Abl signaling through the PI-3/S6 kinase pathway inhibits nuclear translocation of the transcription factor Bach2, which represses the antiapoptotic factor heme oxygenase-1
- Chikashi Yoshida, Fumiko Yoshida, Daniel E. Sears, Stephen M. Hart, Dai Ikebe, Akihiko Muto, Subham Basu, Kazuhiko Igarashi, and Junia V. Melo
Blood 2007; 109: 1211-1219.
[Abstract]
[Full text]
[PDF]
Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications
- Natalia Gonzalez-Paz, Wee J. Chng, Rebecca F. McClure, Emily Blood, Martin M. Oken, Brian Van Ness, C. David James, Paul J. Kurtin, Kimberly Henderson, Gregory J. Ahmann, Morie Gertz, Martha Lacy, Angela Dispenzieri, Philip R. Greipp, and Rafael Fonseca
Blood 2007; 109: 1228-1232.
[Abstract]
[Full text]
[PDF]
Expression of a bcr-1 isoform of RAR -PML does not affect the penetrance of acute promyelocytic leukemia or the acquisition of an interstitial deletion on mouse chromosome 2
- Matthew J. Walter, Rhonda E. Ries, Jon R. Armstrong, John S. Park, Elaine R. Mardis, and Timothy J. Ley
Blood 2007; 109: 1237-1240.
[Abstract]
[Full text]
[PDF]
Long-term serial analysis of X-chromosome inactivation patterns and JAK2 V617F mutant levels in patients with essential thrombocythemia show that minor mutant-positive clones can remain stable for many years
- Rosemary E. Gale, Anthony J.R. Allen, Michael J. Nash, and David C. Linch
Blood 2007; 109: 1241-1243.
[Abstract]
[Full text]
[PDF]
|
|
